Drugs / Adipose derived stem cells
Adipose derived stem cells
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT02645305 | Jun 2015 → Sep 2016 | chronic obstructive pulmonary disease | University of Science Ho Chi Minh City | Unknown | No outcome recorded |
| Phase 1/2 | NCT01584713 | Dec 2011 → Jul 2012 | intestinal fistula | Instituto de Investigación Hospital Universitario La Paz | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02092870 | Sep 2013 → Sep 2015 | decubitus ulcer, ulcer of lower limbs | Tower Outpatient Surgical Center | Completed | No outcome recorded |
| Phase 2 | NCT01586715 | Mar 2012 → May 2013 | anal fistula | Instituto de Investigación Hospital Universitario La Paz | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT03388840 | Jan 2018 → Jan 2021 | androgenetic alopecia | Assiut University | Unknown | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT02923219 | Jan 2017 → Jan 2020 | — | Xuzhou Medical University | Unknown | No outcome recorded |
| — | NCT02024269 | Dec 2013 → Dec 2016 | dry age related macular degeneration | Bioheart, Inc. | Withdrawn | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT02756884 Comparator | Jun 2015 → Jan 2019 | peripheral arterial disease | Arkansas Heart Hospital | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Adipose derived stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03388840 ↗ |
| Known as | ADSCs | “One group will receive Adipose Derived Stem Cells (ADSCs) alone and the other group will receive low frequency ultrasound before the addition of ADSCs.” NCT02756884 ↗1“features of adipose- derived stem cells (ADSCs).” PMID 32269011 ↗ Nov 2019 |
| Known as | Autologous Stem Cells | “autologous e-ASC (Autologous Stem Cells)” NCT01586715 ↗ |
| Known as | e-ASC | “autologous e-ASC (Autologous Stem Cells)” NCT01586715 ↗ |
| Modality | Cell therapy | “Administration will be intralesional injection of cells suspension.” NCT01584713 ↗ |
| Route | Other | “Administration will be intralesional injection of cells suspension.” NCT01584713 ↗ |